The impact of practice guidelines and funding policies on the use of new drugs in advanced non‐small cell lung cancer

, , &
Journal of Evaluation in Clinical Practice 11 (4):350-356 (2005)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2005.00546.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Justice and Lung Cancer.Aaron Wilson - 2013 - Journal of Medicine and Philosophy 38 (2):219-234.
Impact of initial pattern of care on hospital costs in a cohort of incident lung cancer cases.Eva Pagano, Dario Gregori, Claudia Filippini, Daniela Di Cuonzo, Enrico Ruffini, Roberto Zanetti, Stefano Rosso, Oscar Bertetto, Franco Merletti & Giovannino Ciccone - 2012 - Journal of Evaluation in Clinical Practice 18 (2):269-275.
Monitoring the care of lung cancer patients: linking audit and care pathways.E. Kaltenthaler, A. McDonnell & J. Peters B. Tech - 2001 - Journal of Evaluation in Clinical Practice 7 (1):13-20.
Explaining inequalities in access to treatment in lung cancer.Ruth H. Jack, Martin C. Gulliford, Jamie Ferguson & Henrik Møller - 2006 - Journal of Evaluation in Clinical Practice 12 (5):573-582.
Baseline radiological staging in primary breast cancer: impact of educational interventions on adherence to published guidelines.Elaine McWhirter, Geetha Yogendran, Frances Wright, George Dranitsaris M. Pharm & Mark Clemons - 2007 - Journal of Evaluation in Clinical Practice 13 (4):647-650.
Adapting lung cancer symptom investigation and referral guidelines for general practitioners in Australia: Reflections on the utility of the ADAPTE framework.Samantha P. Chakraborty, Kay M. Jones & Danielle Mazza - 2014 - Journal of Evaluation in Clinical Practice 20 (2):129-135.
Role of Race in Survival among Patients Who Refuse the Recommended Surgery for Early Stage Non-Small Cell Lung Cancer: A Seer Cohort Study.Rohtesh S. Mehta - 2011 - Journal of Clinical Research and Bioethics 2 (8).
Comparing treatment trends for colorectal cancer in clinical database and cancer registry data: implications for monitoring cancer care.Ashu Sehgal & Elizabeth A. Davies - 2011 - Journal of Evaluation in Clinical Practice 17 (3):486-492.
The application of pharmacoeconomic modelling to estimate a value‐based price for new cancer drugs.George Dranitsaris, Ilse Truter, Martie S. Lubbe, Wayne Cottrell, Biljana Spirovski & Jonathan Edwards - 2012 - Journal of Evaluation in Clinical Practice 18 (2):343-351.
Variations in the management of cancer in the NHS: a legitimate cause for concern?I. H. Kunkler - 1997 - Journal of Evaluation in Clinical Practice 3 (3):173-177.
Personalized Cancer Care in an Age of Anxiety.Susan Gilbert - 2010 - Hastings Center Report 40 (5):18-21.
Evaluation of changes in guidelines for medication management of stable chronic obstructive pulmonary disease.Fang‐Ju Lin, Todd A. Lee, Pei Shieen Wong & A. Simon Pickard - 2013 - Journal of Evaluation in Clinical Practice 19 (5):953-960.
Making Fair Funding Decisions for High Cost Cancer Care: The Case of Herceptin in New Zealand.E. Fenton - 2010 - Public Health Ethics 3 (2):137-146.
It's simple--we use the extra money to treat lung cancer.M. Duffy T. Curry - 1993 - In Jonathan Westphal & Carl Avren Levenson (eds.), Time. Hackett Pub. Co.. pp. 142--5.

Analytics

Added to PP
2013-11-24

Downloads
49 (#318,154)

6 months
3 (#1,002,413)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references